4272
NIPPON KAYAKU CO.,LTD.
日本化薬
- Industry
- Chemicals
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2021
173,381
Mar 2022
184,805
Mar 2023
198,380
Mar 2024
201,791
Mar 2025
222,584
Operating profit(million JPY)
Mar 2021
15,194
Mar 2022
21,050
Mar 2023
21,505
Mar 2024
7,337
Mar 2025
20,401
Operating profit margin(%)
Mar 2021
8.76
Mar 2022
11.39
Mar 2023
10.84
Mar 2024
3.64
Mar 2025
9.17
Profit before tax(million JPY)
Mar 2021
17,523
Mar 2022
23,700
Mar 2023
20,972
Mar 2024
7,205
Mar 2025
22,007
Profit(million JPY)
Mar 2021
12,574
Mar 2022
17,181
Mar 2023
14,984
Mar 2024
4,113
Mar 2025
17,508
Total assets(million JPY)
Mar 2021
294,535
Mar 2022
315,459
Mar 2023
322,858
Mar 2024
363,173
Mar 2025
373,708
Cash and cash equivalents(million JPY)
Mar 2021
47,483
Mar 2022
52,962
Mar 2023
53,096
Mar 2024
64,777
Mar 2025
57,926
Cash flows from operating activities(million JPY)
Mar 2021
24,408
Mar 2022
23,141
Mar 2023
20,039
Mar 2024
23,242
Mar 2025
25,530
Cash flows from investing activities(million JPY)
Mar 2021
-17,606
Mar 2022
-10,641
Mar 2023
-15,158
Mar 2024
-19,409
Mar 2025
-27,313
Cash flows from financing activities(million JPY)
Mar 2021
-8,402
Mar 2022
-11,090
Mar 2023
-7,950
Mar 2024
3,823
Mar 2025
-4,756
Return on equity(%)
Mar 2021
5.8
Mar 2022
7.3
Mar 2023
6
Mar 2024
1.6
Mar 2025
6.5
Equity ratio(%)
Mar 2021
77.2
Mar 2022
77.8
Mar 2023
78.7
Mar 2024
74.2
Mar 2025
71.6
Earnings per share(JPY per share)
Mar 2021
73.62
Mar 2022
101.7
Mar 2023
89.36
Mar 2024
24.8
Mar 2025
107.17
Net assets per share(JPY per share)
Mar 2021
1,332.06
Mar 2022
1,459.06
Mar 2023
1,532.35
Mar 2024
1,625.18
Mar 2025
1,673.24
Dividend per share(JPY per share)
Mar 2021
30
Mar 2022
40
Mar 2023
45
Mar 2024
45
Mar 2025
60
Payout ratio(%)
Mar 2021
40.75
Mar 2022
39.33
Mar 2023
50.36
Mar 2024
181.45
Mar 2025
55.99
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.